Related Experiment Video
Updated: Jun 4, 2026
08:30
Operant Procedures for Assessing Behavioral Flexibility in Rats
Published on: February 15, 2015
Reexamining shift work pharmacists in Illinois
Ana C Quiñones1, Rachael F Pullin
1Department of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, 555-31st Street, Downers Grove, IL 60515, USA. aquino@midwestern.edu
Research in Social & Administrative Pharmacy : RSAP
|January 29, 2011
Summary
Pharmacists working shifts, particularly evening and night shifts, differ from their non-shift counterparts. These shift-work pharmacists spend more time dispensing medications and less on management tasks.
Area of Science:
- Pharmacy Practice
- Workforce Studies
- Health Services Research
Background:
- Shift work among pharmacists may influence workforce dynamics and service delivery.
- Understanding unique pharmacist characteristics is crucial for labor supply planning.
Purpose of the Study:
- To characterize shift-work pharmacists.
- To compare shift-work pharmacists with non-shift work pharmacists.
- To analyze differences based on shift schedule types.
Main Methods:
- A Biennial Pharmacist Compensation Survey was administered to a random sample of Illinois pharmacists in 2007.
- Pharmacists were categorized based on receiving shift differential pay.
- Descriptive statistics, chi-square, and t tests were employed for comparative analysis.
Main Results:
- Shift-work pharmacists were more likely to be staff hospital pharmacists with children.
- They dedicated more time to dispensing and less to business management.
- Evening and night shifts were the most prevalent alternative schedules.
Conclusions:
- Pharmacists engaged in shift work exhibit distinct characteristics compared to those on standard schedules.
- These findings highlight unique attributes of the shift-work pharmacist population in Illinois.
Related Concept Videos
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...